Сделай Сам Свою Работу на 5

Luetjens CM, Lankiewicz S, Bui NT, Krohn AJ, Poppe M, Prehn JH.

Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury.

Neurosci 2001;102(1):139-150


Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, et al.

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 2000;57(8):1153-60


Luth HJ, Holzer M, Gartner U, Staufenbiel M, Arendt T.

Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

Brain Res 2001;913(1):57-67


Ma J, Qiu J, Hirt L, Dalkara T, Moskowitz MA.

Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia.

Br J Pharmacol 2001;133(3):345-350


Maccioni RB, Munoz JP, Barbeito L.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 2001;32(5):367-381

Marco S, Perez-Navarro E, Tolosa E, Arenas E, Alberch J.

Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.

J Neurobiol 2002;50(4):323-332


Marks N. & Berg MJ.

Secretase and presenilin processing of amyloid precursor provide a basis for immunotherapy and design of clinical agents.

Нейрохимия 2002:19(1); 52-60


Martinez A, Alonso M, Castro A, Perez C, Moreno FJ.

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

J Med Chem 2002;45(6):1292-1299


Martinez M, Fernandez-Vivancos E, Frank A, De la Fuente M, Hernanz A.

Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations.

Brain Res 2000;869(1-2):216-219


Masliah E, Ho G, Wyss-Coray T.

Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice. Neurochem Int 2001;39(5-6):393-400


Mattson MP, Chan SL.

Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci 2001;17(2):205-224


Mattson MP, Gary DS, Chan SL, Duan W.

Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.

Biochem Soc Symp 2001;(67):151-162


Mauler F, Fahrig T, Horvath E, Jork R.

Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.

Brain Res 2001;888(1):150-157


McEwen B.

Estrogen actions throughout the brain. Recent Prog Horm Res 2002;57:357-384


Mehlhorn G, Hollborn M, Schliebs R.

Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.

Int J Dev Neurosci 2000;18(4-5):423-431


Minthon L, Edvinsson L, Gustafson L.

Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia,

Alheim Dis Assoc Disord 1996;10(4):197-203


Mishra OP, Fritz KI, Delivoria-Papadopoulos M.NMDA receptor and neonatal hypoxic brain injury. Ment Retard Dev Disabil Res Rev 2001;7(4):249-253


Montaner J, Alvarez-Sabin J, Barbera G, Angles A, Molina C, Abilleira S.ea.

Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke.

Rev Neurol 2001;33(2): 115-118

De la Monte SM, Lu BX, Sohn YK, Etienne D, Kraft J, Ganju N, Wands JR.

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration.

Neurobiol Aging 2000;21(2):309-319


De la Monte SM, Wands JR.

The ad7c-ntp neuronal thread protein biomarker for detecting Alzheimer's disease. Front Biosci 2002;7:D989-96


Montoliu C, Humet M, Canales JJ, Burda J, Planells-Cases R, Sanchez-Baeza F.

Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants. J Pharmacol Exp Ther 2002;301(1):29-36


Morgan D, et al.

A-beta peptide vaccination prevents memory loss in a animal model of Alzheimer’s disease. Nature 2000;408:982-985


Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, et al.

Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.

J Neurosci 2001;21(19):7551-7560


Mrak RE, Griffin WS.

Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001;22(6):903-908


Mufson EJ, Deecher DC, Basile M, Izenwasse S, Mash DC.

Galanin receptor plasticity within the nucleus basalis in et al.rly and late Alzheimer's disease: an in vitro autoradiographic analysis.

Neuropharm 2000;39(8):1404-1412


Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, et al.

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.

J Comp Neurol 2002;443(2):136-153


Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B, et al.

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.

Neurosci 1999;88(4):1015-1032


Murer MG, Yan Q, Raismanvozari R.

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

Prog Neurobiol 2001;63(1):71-124


Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, et al.

Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.

J Endocrinol Invest 2001;24(3):139-146


Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, et al.Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 2000;14(3):222-227


Nava-Ocampo AA, Reyes-Perez H, Bello-Ramirez AM, Mansilla-Olivares A, et al.

For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?

Med Hypotheses 2000;54 (1):77-79

Nelson RM, Calo G, Guerrini R, Hainsworth AH, Green AR, Lambert DG.

Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices. Neuroreport 2000;11(17):3689-3692


Nicole O, et al.

Neuropro-tection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway.

J Neurosci 2001;21(9):3024-3033.


Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R.

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Peptides 2001;22(12):2105-2112


Nishimura Y, Ito T, Saavedra JM.

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000;31 (10):2478-2486


Nordberg A.

Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 2001;49(3):200-210


Nozaki K, Nishimura M, Hashimoto N.

Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol 2001; 23:1-19


Onoue S, Ohshima K, Endo K, Yajima T, Kashimoto K.

PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment

106-126. FEBS Lett 2002;522(1-3):65-70


Ooboshi H, Ibayashi S, Takano K, Sadoshima S, Kondo A, Uchimura H.

Hypothermia inhibits ischemia-induced efflux of amino acids and neuronal damage in the hippocampus of aged rats.

Brain Res 2000;884(1-2):23-30


Ostrowski RP.

Effect of coenzyme Q(10) on biochemical and morphological changes in experi-mental ischemia in the rat brain.

Brain Res Bull 2000;53(4):399-407


Paganelli R, Di Iorio A, Patricelli L, Ripani F, Sparvieri E, Faricelli R, Iarlori C, et al.Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.

Exp Gerontol 2002;37(2-3):257-263


Papassotiropoulos A, Hock C, Nitsch RM.

Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol Aging 2001;22(6):863-871


Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, Geiger JD.

Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia.

J Neurochem 2000;75(2): 795-802

Pedata F, Corsi C, Melani A, Bordoni F, Latini S.

Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann N Y Acad Sci 2001;939:74-84


Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP.

Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.

Neurobiol Dis 2001;8(3):492-503


©2015- 2019 stydopedia.ru Все материалы защищены законодательством РФ.